z-logo
Premium
Clinical outcomes of kidney transplantation in older end‐stage renal disease patients: A nationwide cohort study
Author(s) -
Ko Eun Jeong,
Yang Jaeseok,
Ahn Curie,
Kim Myoung Soo,
Han Duck Jong,
Kim Sung Joo,
Yang Chul Woo,
Chung Byung Ha
Publication year - 2019
Publication title -
geriatrics and gerontology international
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.823
H-Index - 57
eISSN - 1447-0594
pISSN - 1444-1586
DOI - 10.1111/ggi.13630
Subject(s) - medicine , incidence (geometry) , desensitization (medicine) , cohort , transplantation , kidney transplantation , end stage renal disease , young adult , disease , cohort study , cause of death , physics , receptor , optics
Aim The aim of the present study was to investigate the clinical outcomes of kidney transplantation (KT) in elderly recipients compared with those in young recipients. Methods We compared the incidence of biopsy‐proven acute rejection, death‐censored allograft survival and all‐cause mortality, and also compared the impact of high sensitization or desensitization on the clinical outcomes of elderly and young recipients. Results A total of 4966 KT recipients from the Korean Organ Transplantation Registry were included. The definition of elderly recipients was based on age >60 years ( n  = 356), and recipients aged <60 years were defined as young recipients ( n  = 4610). The incidence of biopsy‐proven acute rejection did not differ between the two groups irrespective of the donor type; however, the impact of high sensitization was significant only in young recipients. Being an elderly recipient was an independent risk factor for death‐censored allograft failure in terms of overall and living donor KT, but not with deceased donor KT. In regard to patient death, being an elderly recipient was a significant predictor in general and in the two subgroups, and desensitization showed a significant interaction with death in the elderly recipients in the living donor KT group. Conclusions In conclusion, KT in elderly recipients might be associated with poor allograft or patient survival in general, and especially, desensitization therapy carried out in these patients might increase the risk of patient mortality. Geriatr Gerontol Int 2019; 19: 392–398 .

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here